Autopsy report · NCT01950468

A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes

“The entire drug development program for this molecule was sold to another company.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Navidea Biopharmaceuticals

Sponsor type

Industry

Conditions

Parkinson's Syndrome

Interventions

NAV5001; DaTscan

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
  “Pharmaceutical collaborator pulled funding.” (69% match in meaning)
• A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19
  “The company decision that terminated the further develop of the molecule and had notified FDA about the termination as well.” (64% match in meaning)
• Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo
  “Changes in drug development plans” (64% match in meaning)
• A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascending Doses of GDC-0334 and the Effect of Food on the Pharmacokinetics of GDC-0334 in Healthy Adult Participants
  “Molecule development was terminated” (62% match in meaning)
• A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC
  “Company decided not to pursue the development of this drug in this patient population at this time” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.